more_reports

BrainStorm Cell Therapeutics Inc.

BCLI:NASDAQ

BrainStorm Cell Therapeutics Inc. is developing a platform technology based on autologous mesenchymal stem cells that have been induced to secrete a variety of neurotrophic factors. The company is in a Phase 2 trial in ALS after having seen excellent safety and efficacy in earlier clinical studies.

streetwise book logo Streetwise Company Fact Sheet

2024/7/17 19:16:07

(BCLI:NASDAQ)